Development of AVIPure® - AAV9: The first highly reusable AAV affinity resin with NaOH cleaning capabilities

High doses of AAV are becoming increasingly common in gene therapies. In order to meet the growing and ever-changing needs of the biopharmaceutical industry, Avitide has developed the world's first highly reusable affinity chromatography resin with sodium hydroxide (NaOH) cleaning capabilities - AVIPure® - AAV9.

Thomas Scanlon, Ph.D.

Director of Ligand Discovery

Join Tom Scanlon, PhD, Director of Ligand Discovery at Avitide as he discusses Avitide’s affinity resin development platform, AVIPure® - AAV9 Development, and market drivers for AAV resin reuse. AVIPure® - AAV9 resin is manufactured on site at Avitide headquarters in Lebanon, New Hampshire and is AVAILABLE NOW for commercial manufacturing applications.

    By clicking this button, you submit your information to the Avitide who may use it to communicate with you regarding this content or their other services.

    16 Cavendish Court
    Lebanon, NH 03766

    email us

    Privacy Policy

    Terms of Use

    © 2021 Avitide

    All Rights Reserved

    Subscribe to hear the latest news and insights…